Abingworth

About Abingworth

Abingworth LLP is a life science investment firm focused on working with entrepreneurs to transform breakthrough science into innovative medicines. With over thirty years of experience, they support young biopharma companies across the Atlantic by providing time, patience, determination, experience, and capital to turn scientific discoveries into new treatments for patients.

Products & Services

Life Science Investments:Investing in early-stage biopharma companies to support the development of new therapeutics.

VIPEs (Venture Investments in Public Equities):A pioneering approach to investing in public biotech companies.

Clinical Co-Development:A novel strategy to support clinical development in portfolio companies.

Specialties

Biotech Investments Early-Stage Biopharma Funding Clinical Co-Development Venture Investments in Public Equities (VIPEs) Transatlantic Biotech Support

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Fund T: - FT: Fund	A: 356000000 MR: - FA: $356 million FAN: 356000000	D: 2023-10-30 FD: 2023-10-30	-

Fund Latest

2023-10-30

$356.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kurt von Emster

Managing Partner & Head of Abingworth Life Sciences

B

Bali Muralidhar

Managing Partner, Chief Investment Officer & COO

J

Jayson Punwani

Head of Venture

A

Andrew Sinclair

Head of Publics & Late Stage

L

Lucille Conroy

Principal

R

Robert DeBenedetto

Managing Director, CCD

View 28 more team members with Pro

Unlock Full Team Directory

Recent News

Abingworth Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised